iBio, Inc. (IBIO): Cost of Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cost of Revenue is for the year ended 2022-06-30, while the company's latest annual report covers the year ended 2026-06-30. Its later filings do not report this line under the concept TickerFacts maps.

$216.0K
Year ended 2022-06-30
$1.46M2020-06-30: $703.0K2021-06-30: $1.46M2022-06-30: $216.0K$216.0K
2020-06-30 Cost of Revenue (USD) 2022-06-30
Period endedCost of RevenueChange YoYSource filing
2022-06-30$216.0K-85.2%2022-10-11, From 2021-07-01
2021-06-30$1.46M+108.0%2022-10-11, From 2020-07-01
2020-06-30$703.0Kn/a2021-09-28, From 2019-07-01